Berberine is an unlicensed supplement with modest effects and limited evidence, whilst GLP-1 receptor agonists are rigorously tested, MHRA-licensed medicines with proven efficacy for type 2 diabetes management under medical supervision
Preclinical research suggests it may support the bodys recovery efforts by promoting angiogenesis, encouraging cellular migration, assisting with tissue remodeling, and helping regulate inflammation
The involvement of proinflammatory cytokines in diabetic nephropathy: focus on interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-) signaling mechanism
No therapeutic or clinical claims are made or implied
For study 1 (weight loss study of GLP-1MK-801 relative to monotherapies), mice were randomly divided into four experimental groups ( n = 8 mice per group) with similar mean body weights and assigned to receive once-daily s.c